WntResearch’s CEO Henrik Lawaetz and Chief Scientific Officer Tommy Andersson have been invited to present the company's drug projects Foxy-5 and Box 5 at the by-invitation-only conference “Oncology Opportunities in Medicon Valley”, which takes place in Malmö on October 6, 2016.

"We welcome this opportunity to have a dialogue with a number of global pharmaceutical companies that have shown interest in Scandinavian biotech companies active within the area of oncology," says Henrik Lawaetz, CEO, WntResearch.

The main theme for the conference, organized by Invest in Skåne and Copenhagen Capacity, is "Cancer Research and ecosystem in Medicon Valley - Focus on novel cancer therapies". Representatives from Johnson & Johnson, Bristol-Myers Squibb, Pfizer, Abbvie and Eli Lilly will participate in the meeting.